"Seeing inside the body": MR imaging of gene expression

Abstract. The goal of this review is to describe the developments and recent advances that are enabling applications of magnetic resonance (MR) imaging for non-invasive imaging of gene expression. Guiding application of this technology has been the need to test, in vivo and in real time, hypotheses developed in multiple scientific fields. Advances made in the human genome project and our increasing understanding of the molecular basis of normal and disease physiology have defined questions that will only be answered when specific molecular imaging modalities are developed. In this review we will briefly summarize the salient features of MR imaging to provide the backdrop for a more detailed discussion of specific applications of MR imaging of gene expression. We will conclude with the insights gained from genomic approaches and how they might be exploited for MR imaging of gene expression in the future.

[1]  Ralph Weissleder,et al.  Magnetic Nanosensors for the Detection of Oligonucleotide Sequences. , 2001, Angewandte Chemie.

[2]  Sayan Mukherjee,et al.  Molecular classification of multiple tumor types , 2001, ISMB.

[3]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[4]  H. Sussman,et al.  Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells , 1981, International journal of cancer.

[5]  B J McNeil,et al.  Advances in biomedical imaging. , 2001, JAMA.

[6]  R Weissleder,et al.  Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays. , 1992, Radiology.

[7]  R Weissleder,et al.  MR imaging and scintigraphy of gene expression through melanin induction. , 1997, Radiology.

[8]  T J Brady,et al.  MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. , 1990, AJR. American journal of roentgenology.

[9]  R E Jacobs,et al.  Looking deeper into vertebrate development. , 1999, Trends in cell biology.

[10]  Alexander Petrovsky,et al.  Oligomerization of Paramagnetic Substrates Result in Signal Amplification and Can be Used for MR Imaging of Molecular Targets , 2002, Molecular imaging.

[11]  G. Johnson,et al.  Magnetic resonance microscopy of mouse embryos. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L W Hedlund,et al.  Histology by magnetic resonance microscopy. , 1993, Magnetic resonance quarterly.

[13]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[14]  R. Strausberg,et al.  Identifying potential tumor markers and antigens by database mining and rapid expression screening. , 2000, Genome research.

[15]  A. Butte,et al.  Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Brünner,et al.  Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials , 1993, Journal of cellular physiology.

[17]  W. Ebert,et al.  The Demonstration of Human Tumors on Nude Mice Using Gadolinium‐Labelled Monoclonal Antibodies for Magnetic Resonance Imaging , 1993, Investigative radiology.

[18]  T J Brady,et al.  Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. , 1996, Bioconjugate chemistry.

[19]  M. Greaves,et al.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Recht,et al.  Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. , 1990, Journal of neurosurgery.

[21]  Nir Friedman,et al.  Tissue classification with gene expression profiles. , 2000 .

[22]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[23]  R Weissleder,et al.  Measuring transferrin receptor gene expression by NMR imaging. , 1998, Biochimica et biophysica acta.

[24]  M. Omary,et al.  Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Larson,et al.  Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.

[26]  A. Ergen,et al.  Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder. , 1991, British journal of urology.

[27]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[28]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[29]  T J Brady,et al.  Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. , 1992, Radiology.

[30]  E C Wiener,et al.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. , 2000, Investigative radiology.

[31]  R Weissleder,et al.  Molecular imaging. , 2009, Radiology.

[32]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[33]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.